Some successful examples of this approach have been demonstrated in GWAS on AD biomarkers and endophenotypes, including amyloid and tau [134–137], neurofilament light (NFL) [138, 139], neuropathologic features [140] resilience [141], psychosis [142], and AAO [132, 143–145], resulting in novel loci. This evidence concerns the gene MAPT and Alzheimer disease.